Skip to main content
Wilson Mertens, MD, Oncology, Springfield, MA

WilsonCMertensMDMSBA

Oncology Springfield, MA

Breast Cancer, Genitourinary Oncology, Head & Neck Cancer, Thoracic Cancer

Semi-Retired Medical Oncologist/Physician Executive; Former Vice President and Medical Director, Cancer Services, Baystate Health; Professor of Medicine, UMass Chan Medical School-Baystate

Dr. Mertens is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mertens' full profile

Already have an account?

  • Office

    3350 Main St
    Springfield, MA 01107
    Phone+1 413-794-9338
    Fax+1 413-794-3307

Education & Training

  • School of Business, Madonna University
    School of Business, Madonna University MS, Business Administration, 1998 - 2000
  • London Regional Cancer Centre, Ontario Cancer Treatment & Research Foundation, University of Western Ontario
    London Regional Cancer Centre, Ontario Cancer Treatment & Research Foundation, University of Western OntarioFellow, 1986 - 1988
  • University of Western Ontario
    University of Western OntarioResident, 1983 - 1986
  • University of Western Ontario
    University of Western OntarioInternship, 1982 - 1983
  • University of Western Ontario
    University of Western OntarioClass of 1982
  • The University of Western Ontario
    The University of Western OntarioBS, Honors Chemistry Program, 1976 - 1978

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2000 - 2026
  • MI State Medical License
    MI State Medical License 1994 - 2023
  • PA State Medical License
    PA State Medical License 1994 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology
  • Royal College of Physicians and Surgeons of CanadaInternal Medicine
  • Royal College of Physicians and Surgeons of CanadaMedical Oncology

Awards, Honors, & Recognition

  • Best Doctors in America ® 2009, 2010, 2011
  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
  • Cambridge’s Who’s Who Healthcare and Administration, 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The treatment of hypercalcemia.  
    Mertens, W.C, Pain Management Newsletter
  • Systemic radionuclides in the treatment of symptomatic bony metastases: The clinical trial era arrives.  
    Mertens, W.C., Porter, A.T., Int Oncol Monitor

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Differential aspects of sleep epilepsy.
    Young, G.B., Blume, W.T., Wells, G.A., Mertens, W.C., Eder, S, Can J. Neurol Sci
  • Pre-and post-operative chemotherapy for soft tissuee sarcoma.
    Mertens, W. Bramwell, V, Proc Joint Warsaw Workshop on Adjuvant chemotherapy, Poland
  • Strontium-89 in the treatment of metastatic prostate carcinoma.
    Porter, A.T., Mertens, W.C, Can. J. Oncol
  • Join now to see all

Lectures

  • Breast and head and neck cancer: current controversies, treatments, and outcome measures. 
    American Academy of Physical Medicine and Rehabilitation, Phoenix, AZ
  • Marketing Oncology: Service Line Strategies for Marketers. 
    HCPro Healthcare Marketplace. Webinar
  • Patient Experience Design: An Experience Report. 
    LEAP Forward Conference, Park City, UT
  • Join now to see all

Other

Press Mentions

  • Dr. Wilson Mertens: How Can We Deliver the Best Cancer Care to All?
    Dr. Wilson Mertens: How Can We Deliver the Best Cancer Care to All?September 3rd, 2019
  • Local Cancer Center Treats More Than 7,000 Patients a Year
    Local Cancer Center Treats More Than 7,000 Patients a YearJune 10th, 2019
  • Dr. Wilson Mertens: Defining ‘Probable Human Carcinogens’
    Dr. Wilson Mertens: Defining ‘Probable Human Carcinogens’May 6th, 2019